Product Code: GVR-4-68040-638-2
Market Size & Trends:
The U.S. analytical instrumentation market size was valued at USD 24.10 billion in 2024 and is anticipated to grow at a CAGR of 3.5% from 2025 to 2030. Analytical instrumentation refers to a wide range of laboratory tools used for the identification, separation, and quantification of chemical substances in natural and synthetic materials. In the U.S., these instruments play a critical role in various sectors, including environmental monitoring, food safety, pharmaceuticals, and biotechnology. Analytical tools such as mass spectrometers, chromatography systems (e.g., HPLC and GC), spectrophotometers, and NMR spectrometers are widely used in U.S. laboratories to provide quantitative and qualitative data on the presence and concentration of specific components within a sample.
Growing interest in precision medicine in the U.S. is expected to boost demand for analytical instruments during the forecast period. These tools are essential for accurately diagnosing diseases and developing personalized treatments. Technologies like genomic sequencing help identify the best therapies based on a patient's unique genetic makeup. Advanced microscopy methods, such as cryogenic electron microscopy, are also widely used in drug discovery to study the structure of proteins and support the development of new medications.
Recent innovations in the analytical instrumentation industry include nanoscale vibrational imaging techniques such as TERS and IR s-SNOM; the tools offer an understanding of molecular details for chemical and biological systems. Other key innovations include miniature mass spectrometers for on-the-go analysis and MaxPeak HPS Technology, which improves liquid chromatography accuracy by reducing sample loss and signal distortion, especially for sensitive molecules like peptides and nucleic acids.
The U.S. analytical instrumentation market is subject to high regulatory impact as the instruments are used in pharmaceuticals, monitoring, and food safety sectors. The instruments must comply with strict federal standards enforced by authorities such as the FDA, EPA, and USDA. These regulations ensure the reliability and safety of the instruments and provide compliance-driven innovations.
U.S. Analytical Instrumentation Market Report Segmentation
This report forecasts revenue growth and provides an analysis of the latest trends in each of the sub-segments from 2018 to 2030. For the purpose of this report, Grand View Research has segmented U.S. analytical instrumentation market on the basis of product, technology, application:
- Product Outlook (Revenue, USD Billion, 2018 - 2030)
- Instruments
- Services
- Software
- Technology Outlook (Revenue, USD Billion, 2018 - 2030)
- Polymerase Chain Reaction
- Spectroscopy
- Microscopy
- Chromatography
- Flow Cytometry
- Sequencing
- Microarray
- Others
- Application Outlook (Revenue, USD Billion, 2018 - 2030)
- Life Sciences Research & Development
- Clinical & Diagnostic Analysis
- Food & Beverage Analysis
- Forensic Analysis
- Environmental Testing
- Others
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Product
- 1.2.2. Technology
- 1.2.3. Application
- 1.2.4. Estimates and forecasts timeline
- 1.3. Research Methodology
- 1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
- 1.4.5. Details of primary research
- 1.5. Information or Data Analysis
- 1.5.1. Data analysis models
- 1.6. Market Formulation & Validation
- 1.7. Model Details
- 1.8. List of Secondary Sources
- 1.9. List of Primary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Outlook
- 2.2.1. Product outlook
- 2.2.2. Technology outlook
- 2.2.3. Application outlook
- 2.3. Competitive Insights
Chapter 3. U.S. Analytical Instrumentation Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.2. Market restraint analysis
- 3.3. U.S. Analytical Instrumentation Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.1.1. Supplier power
- 3.3.1.2. Buyer power
- 3.3.1.3. Substitution threat
- 3.3.1.4. Threat of new entrant
- 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
- 3.3.2.1. Political landscape
- 3.3.2.2. Technological landscape
- 3.3.2.3. Economic landscape
- 3.4. U.S. Analytical Instrumentation Market: Pipeline Analysis
Chapter 4. U.S. Analytical Instrumentation Market: Product Estimates & Trend Analysis
- 4.1. Product Segment Dashboard
- 4.2. U.S. Analytical Instrumentation Market: Product Movement Analysis
- 4.3. U.S. Analytical Instrumentation Market Size & Trend Analysis, by Product, 2018 to 2030 (USD Million)
- 4.4. Instruments
- 4.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 4.5. Services
- 4.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 4.6. Software
- 4.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 5. U.S. Analytical Instrumentation Market: Technology Estimates & Trend Analysis
- 5.1. Technology Segment Dashboard
- 5.2. U.S. Analytical Instrumentation Market: Technology Movement Analysis
- 5.3. U.S. Analytical Instrumentation Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Billion)
- 5.4. Polymerase Chain Reaction
- 5.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.5. Spectroscopy
- 5.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.6. Microscopy
- 5.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.7. Chromatography
- 5.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.8. Flow Cytometry
- 5.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.9. Sequencing
- 5.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.10. Microarray
- 5.10.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 5.11. Others
- 5.11.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 6. U.S. Analytical Instrumentation Market: Application Estimates & Trend Analysis
- 6.1. Application Segment Dashboard
- 6.2. U.S. Analytical Instrumentation Market: Application Movement Analysis
- 6.3. U.S. Analytical Instrumentation Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
- 6.4. Life Sciences Research & Development
- 6.4.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.5. Clinical & Diagnostic Analysis
- 6.5.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.6. Food & Beverage Analysis
- 6.6.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.7. Forensic Analysis
- 6.7.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.8. Environmental Testing
- 6.8.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
- 6.9. Others
- 6.9.1. Market Estimates and Forecasts 2018 to 2030 (USD Billion)
Chapter 7. Competitive Landscape
- 7.1. Recent Developments & Impact Analysis, By Key Market Participants
- 7.2. Company/Competition Categorization
- 7.3. Vendor Landscape
- 7.3.1. Key company heat map analysis, 2024
- 7.4. Company Profiles
- 7.4.1. Thermo Fisher Scientific, Inc.
- 7.4.1.1. Company overview
- 7.4.1.2. Financial performance
- 7.4.1.3. Product benchmarking
- 7.4.1.4. Strategic initiatives
- 7.4.2. Danaher
- 7.4.2.1. Company overview
- 7.4.2.2. Financial performance
- 7.4.2.3. Product benchmarking
- 7.4.2.4. Strategic initiatives
- 7.4.3. Agilent Technologies, Inc.
- 7.4.3.1. Company overview
- 7.4.3.2. Financial performance
- 7.4.3.3. Product benchmarking
- 7.4.3.4. Strategic initiatives
- 7.4.4. Bruker Corp.
- 7.4.4.1. Company overview
- 7.4.4.2. Financial performance
- 7.4.4.3. Product benchmarking
- 7.4.4.4. Strategic initiatives
- 7.4.5. PerkinElmer, Inc.
- 7.4.5.1. Company overview
- 7.4.5.2. Financial performance
- 7.4.5.3. Product benchmarking
- 7.4.5.4. Strategic initiatives
- 7.4.6. Mettler Toledo
- 7.4.6.1. Company overview
- 7.4.6.2. Financial performance
- 7.4.6.3. Product benchmarking
- 7.4.6.4. Strategic initiatives
- 7.4.7. Bio-Rad Laboratories, Inc.
- 7.4.7.1. Company overview
- 7.4.7.2. Financial performance
- 7.4.7.3. Product benchmarking
- 7.4.7.4. Strategic initiatives
- 7.4.8. Illumina, Inc.
- 7.4.8.1. Company overview
- 7.4.8.2. Financial performance
- 7.4.8.3. Product benchmarking
- 7.4.8.4. Strategic initiatives
- 7.4.9. F. Hoffmann-La Roche AG
- 7.4.9.1. Company overview
- 7.4.9.2. Financial performance
- 7.4.9.3. Product benchmarking
- 7.4.9.4. Strategic initiatives
- 7.4.10. Avantor, Inc.
- 7.4.10.1. Company overview
- 7.4.10.2. Financial performance
- 7.4.10.3. Product benchmarking
- 7.4.10.4. Strategic initiatives